NovaBridge Biosciences (NBP) Treasury Shares (2018 - 2026)

NovaBridge Biosciences (NBP) has reported Treasury Shares for 5 consecutive years, with -$5.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Treasury Shares rose 19.0% year-over-year to -$5.0 million; the TTM figure through Dec 2025 stood at -$5.0 million (up 19.0% YoY), while the FY2025 annual figure was -$5.0 million, up 19.0% from the prior year.
• Treasury Shares rose to -$5.0 million in Q4 2025 per NBP's latest filing, from -$5.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $6.8 million in Q2 2024 and bottomed at $231766.3 in Q4 2021.
• Historically, Treasury Shares has averaged $3.6 million across 5 years, with a median of $5.4 million in 2025.
• Annual changes were most pronounced in 2023 — Treasury Shares jumped 164.06% — and 2024, when it tumbled 178.91%.
• NovaBridge Biosciences' Treasury Shares stood at $3.0 million in 2022, then surged by 164.06% to $7.9 million in 2023, then tumbled by 178.91% to -$6.2 million in 2024, then advanced by 19.0% to -$5.0 million in 2025.
• Business Quant data shows NBP's Treasury Shares at -$5.0 million in Q4 2025, -$5.2 million in Q3 2025, and -$5.6 million in Q2 2025.